PFIZER ACQUIRES GLOBAL RIGHTS OF SCHWARZ PHARMA'S NEW DRUG

Pharmaceutical giant Pfizer Inc (PFE.NYS) Tuesday announced that it had completed the acquisition of the worldwide rights of Schwarz Pharma AG's (SRZ) new drug candidate, fesoterodine, for the treatment of an overactive bladder.

Newratings (http://www.newratings.com/analyst_news/article_1296059.html)